BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17879940)

  • 1. 17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.
    Qiao Y; Zhang ZK; Cai LQ; Tan C; Imperato-McGinley JL; Zhu YS
    Prostate; 2007 Dec; 67(16):1719-28. PubMed ID: 17879940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells.
    Weng C; Cai J; Wen J; Yuan H; Yang K; Imperato-McGinley J; Zhu YS
    Int J Oncol; 2013 Jan; 42(1):327-37. PubMed ID: 23135751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor isoform and ligand-specific modulation of dihydrotestosterone-induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens.
    Zhu YS; Cai LQ; Huang Y; Fish J; Wang L; Zhang ZK; Imperato-McGinley JL
    J Androl; 2005; 26(4):500-8; discussion 509-10. PubMed ID: 15955889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer.
    Qiao Y; Wang L; Cai LQ; Tan C; Imperato-McGinley J; Zhu YS
    J Urol; 2011 Jan; 185(1):305-14. PubMed ID: 21075385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells.
    Wen J; Zhao Y; Li J; Weng C; Cai J; Yang K; Yuan H; Imperato-McGinley J; Zhu YS
    Prostate; 2013 Jul; 73(10):1069-81. PubMed ID: 23423946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.
    Montgomery B; Nelson PS; Vessella R; Kalhorn T; Hess D; Corey E
    BMC Cancer; 2010 May; 10():244. PubMed ID: 20509933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
    Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
    Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.
    Xi SC; Tam PC; Brown GM; Pang SF; Shiu SY
    J Pineal Res; 2000 Oct; 29(3):172-83. PubMed ID: 11034115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.
    Mori A; Lehmann S; O'Kelly J; Kumagai T; Desmond JC; Pervan M; McBride WH; Kizaki M; Koeffler HP
    Cancer Res; 2006 Mar; 66(6):3222-9. PubMed ID: 16540674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
    Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
    Zhou JR; Yu L; Zhong Y; Nassr RL; Franke AA; Gaston SM; Blackburn GL
    Prostate; 2002 Oct; 53(2):143-53. PubMed ID: 12242729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.
    Ryan CJ; Zavodovskaya M; Youngren JF; Campbell M; Diamond M; Jones J; Shiry L; Allan G; Maddux BA; Goldfine ID
    Prostate; 2008 Aug; 68(11):1232-40. PubMed ID: 18491370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo.
    Landriscina M; Bagalà C; Piscazzi A; Schinzari G; Quirino M; Fabiano A; Bianchetti S; Cassano A; Sica G; Barone C
    Prostate; 2009 May; 69(7):744-54. PubMed ID: 19152342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
    Moss PE; Lyles BE; Stewart LV
    Exp Cell Res; 2010 Dec; 316(20):3478-88. PubMed ID: 20932825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S
    Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways.
    Yang Y; Ikezoe T; Takeuchi T; Adachi Y; Ohtsuki Y; Koeffler HP; Taguchi H
    Oncol Rep; 2006 Jun; 15(6):1581-90. PubMed ID: 16685399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells.
    Casimiro MC; Di Sante G; Ju X; Li Z; Chen K; Crosariol M; Yaman I; Gormley M; Meng H; Lisanti MP; Pestell RG
    Cancer Res; 2016 Jan; 76(2):329-38. PubMed ID: 26582866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.